About Amundi TecDAX UCITS ETF

E908 invests in stocks. The fund's major sectors are Health Technology, with 27.07% stocks, and Technology Services, with 25.59% of the basket. The assets are mostly located in the Europe region.

E908 top holdings are Deutsche Telekom AG and Infineon Technologies AG, occupying 15.75% and 14.42% of the portfolio correspondingly.

E908 last dividends amounted to 0.26 EUR. The year before, the issuer paid 0.25 EUR in dividends, which shows a 3.85% increase.

E908 assets under management is ‪84.27 M‬ EUR. It's fallen 3.77% over the last month.

E908 fund flows account for ‪−267.79 K‬ EUR (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.

E908 shares are issued by SAS Rue la Boétie under the brand Amundi. The ETF was launched on Oct 27, 2016, and its management style is Passive.

E908 expense ratio is 0.40% meaning you'd have to pay 0.40% of your investment to help manage the fund.

E908 follows the Germany TECDAX (TR). ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.

E908 invests in stocks.

E908 price has fallen by −5.88% over the last month, and its yearly performance shows a 6.04% increase. See more dynamics on E908 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by −5.37% over the last month, have fallen by −5.37% over the last month, showed a −7.68% decrease in three-month performance and has increased by 9.33% in a year.